ASMB - Assembly Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue14,8049,019--
Cost of Revenue72,74144,22533,09318,357.937
Gross Profit-57,937-35,206-33,093-18,357.937
Operating Expenses
Research Development----
Selling General and Administrative30,49817,02112,18511,297.693
Non Recurring----
Others----
Total Operating Expenses103,23961,24645,27829,655.63
Operating Income or Loss-88,435-52,227-45,278-29,655.63
Income from Continuing Operations
Total Other Income/Expenses Net-1,2173683991,201.797
Earnings Before Interest and Taxes-88,435-52,227-45,278-29,655.63
Interest Expense----
Income Before Tax-89,652-51,859-44,879-28,453.833
Income Tax Expense1,099-9,050-618-
Minority Interest----
Net Income From Continuing Ops-90,751-42,809-44,261-28,453.833
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-90,751-42,809-44,261-28,453.833
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-90,751-42,809-44,261-28,453.833